Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study (Jan, 10.1038/s41416-022-01713-w, 2022)

被引：0

作者：

Zaibet, Sonia

Hautefeuille, Vincent

Auclin, Edouard

Lievre, Astrid

Tougeron, David

Sarabi, Mathieu

Gilabert, Marine

Wasselin, Julie

Edeline, Julien

Artru, Pascal

Bechade, Dominique

Morin, Clemence

Ducoulombier, Agnes

Taieb, Julien

Pernot, Simon

机构：

[1] Université de Paris,Department of Hepato

[2] SIRIC CARPEM Comprehensive Cancer Center,Gastroenterology and Gastrointestinal Oncology, Hôpital Européen Georges Pompidou

[3] CHU Amiens Picardie,Department of Hepato

[4] Université de Paris,Gastroenterology and Gastrointestinal Oncology

[5] SIRIC CARPEM Comprehensive Cancer Center,Department of Medical Oncology, Hôpital Européen Georges Pompidou

[6] Université de Paris,INSERM, UMR 1138, team 22, Centre de Recherche des Cordeliers

[7] CHU Rennes,Department of Gastroenterology

[8] INSERM U1242,Department of Hepato

[9] CHU Poitiers,Gastroenterology

[10] Centre Léon Bérard,Department of Medical Oncology

[11] Institut Paoli-Calmettes,Department of Medical Oncology

[12] Centre Eugène Marquis,Department of Medical Oncology

[13] Hôpital Privé Jean Mermoz,Department of Hepato

[14] Institut Bergonié,Gastroenterology

[15] Centre Antoine Lacassagne,Department of Medical Oncology

来源：

BRITISH JOURNAL OF CANCER | 2022年 / 126卷 / 06期

关键词：

D O I：

10.1038/s41416-022-01734-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：969 / 969

页数：1

共 50 条

[11] Modified FOLFIRINOX for metastatic pancreatic adenocarcinoma after failure of nab-paclitaxel plus gemcitabine.
Ozaka, Masato
Sasaki, Takashi
Kataoka, Seita
Kanata, Ryo
Ishigaki, Kazunaga
Yamada, Ikuhiro
Matsuyama, Masato
Takano, Koichi
Sasahira, Naoki
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
[12] FOLFIRINOX or nab-paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: an observational study
Servetto, Alberto
Santaniello, Antonio
Napolitano, Fabiana
Foschini, Francesca
Marciano, Roberta
Cascetta, Priscilla
Amato, Anna Rita
Augurio, Maria Rosaria
Maresca, Lucia
De Placido, Pietro
De Placido, Sabino
Formisano, Luigi
Bianco, Roberto
FUTURE ONCOLOGY, 2022, 18 (21) : 2643 - 2654
[13] A Real-World Comparison of FOLFIRINOX, Gemcitabine Plus nab-Paclitaxel, and Gemcitabine in Advanced Pancreatic Cancers
Wang, Ying
Camateros, Pierre
Cheung, Winson Y.
JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (01) : 62 - 68
[14] A Real-World Comparison of FOLFIRINOX, Gemcitabine Plus nab-Paclitaxel, and Gemcitabine in Advanced Pancreatic Cancers
Ying Wang
Pierre Camateros
Winson Y. Cheung
Journal of Gastrointestinal Cancer, 2019, 50 : 62 - 68
[15] Nab paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after failure of folfirinox: Results of an AGEO multicenter prospective cohort
Portal, Alix
Pernot, Simon
Arbaud, Claire
Tougeron, David
Thirot-Bidault, Anne
De La Fouchardiere, Christelle
Hammel, Pascal
Lecomte, Thierry
Dreanic, Johann
Coriat, Romain
Bachet, Jean Baptiste
Dubreuil, Olivier
Marthey, Lysiane
Dahan, Laetitia
Legoux, Jean-Louis
Locher, Christophe
Lepere, Celine
Rougier, Philippe
Bonnetain, Franck
Taieb, Julien
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[16] Successful Treatment with Nab-Paclitaxel and Gemcitabine after FOLFIRINOX Failure in a Patient with Metastasized Pancreatic Adenocarcinoma
Berger, Anne K.
Weber, Tim F.
Jaeger, Dirk
Springfeld, Christoph
ONKOLOGIE, 2013, 36 (12): : 763 - 765
[17] FOLFIRINOX for Advanced Pancreatic Cancer Patients After Nab-Paclitaxel Plus Gemcitabine Failure
Matsumoto, Toshihiko
Kurioka, Yusuke
Okazaki, Ukyo
Matsuo, Yu
Kimura, Shogo
Miura, Kou
Tsuduki, Takao
Takagi, Shinjiro
Takatani, Masahiro
Morishita, Hirofumi
PANCREAS, 2020, 49 (04) : 574 - 578
[18] Real-world experience with FOLFIRINOX and gemcitabine plus nab-paclitaxel in the treatment of pancreatic cancer in Japan
Maeda, O.
Yokoyama, Y.
Yamaguchi, J.
Ota, A.
Matsuoka, A.
Morita, S.
Inoue, M.
Mizutani, T.
Shimokata, T.
Urakawa, H.
Mitsuma, A.
Nagino, M.
Ando, Y.
ANNALS OF ONCOLOGY, 2017, 28 : 69 - 69
[19] First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world population
Hatashima, Alycia
Arango, Matthew J.
Reardon, Joshua
Freeman, Tracelyn
Williams, Terence
McLaughlin, Eric M.
Abushahin, Laith
FUTURE ONCOLOGY, 2022, 18 (20) : 2521 - 2532
[20] EFFICACY OF MODIFIED FOLFIRINOX AS SECOND-LINE CHEMOTHERAPY IN METASTATIC PANCREATIC ADENOCARCINOMA AFTER GEMCITABINE PLUS NAB-PACLITAXEL FAILURE
Ikezawa, Kenji
Kiyota, Ryosuke
Takada, Ryoji
Imai, Toshihiro
Yutaro, Abe
Fukutake, Nobuyasu
Takatoshi, Nawa
Katayama, Kazuhiro
Ohkawa, Kazuyoshi
GASTROENTEROLOGY, 2020, 158 (06) : S527 - S527

← 1 2 3 4 5 →